These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mithramycin treatment of Paget's disease of bone. Exploration of combined mithramycin-EHDP therapy. Ryan WG, Schwartz TB. Arthritis Rheum; 1980 Oct; 23(10):1155-61. PubMed ID: 6158957 [No Abstract] [Full Text] [Related]
4. Treatment of Paget's disease with mithramycin: further experiences. Ryan WG, Schwartz TB, Northrop G. Semin Drug Treat; 1972 Oct; 2(1):57-64. PubMed ID: 4261785 [No Abstract] [Full Text] [Related]
15. [Clinical and metabolic effects of mithramycin and glucagon in the treatment of Paget's disease]. Hadjipavlou AG, Danais S, Greenwood F, Siller TN, Tsoukas GM. Union Med Can; 1978 Sep 15; 107(9):849-56. PubMed ID: 151960 [No Abstract] [Full Text] [Related]
16. [Treatment of Paget's osteitis deformans]. Brixen K, Steiniche T, Mosekilde L, Melsen F. Ugeskr Laeger; 1989 Mar 13; 151(11):677-80. PubMed ID: 2522692 [Abstract] [Full Text] [Related]
17. Mithramycin in Paget's disease of bone. Ryan WG. Lancet; 1973 Jun 09; 1(7815):1319. PubMed ID: 4126107 [No Abstract] [Full Text] [Related]
19. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3. D'Amore M, Carrozzo M, Cantatore FP, Scagliusi P, Pipitone V. Panminerva Med; 1984 Jun 09; 26(1):13-7. PubMed ID: 6233523 [No Abstract] [Full Text] [Related]
20. The role of mithramycin in the management of Paget's disease. Heath DA. Metab Bone Dis Relat Res; 1981 Jun 09; 3(4-5):343-5. PubMed ID: 6220192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]